NAPSI utilization as an evaluation method of nail psoriasis in patients using acitretin;Utilização do NAPSI como instrumento de avaliação na psoríase ungueal em pacientes com uso da acitretina

Anais Brasileiros de Dermatologia

Volumn 87, Issue 2, 2012, Pages 256-262

  Mukai, Maira Mitsue ^a   Poffo, Isabela Fleischfresser ^b   Werner, Betina ^a   Brenner, Fabiane Mulinari ^a   Filho, José Hermênio Cavalcante Lima ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b NONE

Author keywords

Acitretin; Nail diseases; Psoriasis

Indexed keywords

ETRETIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; DRUG DOSE INCREASE; FEMALE; HUMAN; MALE; NAIL PSORIASIS; NAIL PSORIASIS SEVERITY INDEX; OUTCOME ASSESSMENT; PSORIASIS VULGARIS; SCORING SYSTEM; SKIN DEFECT; TREATMENT DURATION;

EID: 84862222018     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/S0365-05962012000200010     Document Type: Article

References (12)

1. Barker JN. The pathophysiology of psoriasis. Lancet. 1991;338:227-30.
2. Jiaravuthisan MM, Sasseville D, Vender RB, Murphy F, Muhn CY. Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. J Am Acad Dermatol. 2007;57:1-27.
3. Cassell S, Kavanaugh AF. Therapies for psoriatic nail disease. A systematic review. J Rheumatol. 2006;33:1452-6.
4. de Berker D. Management of nail psoriasis. Clin Exp Dermatol. 2000;25:357-62.
5. Rich P, Scher RK. Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis. J Am Acad Dermatol. 2003;49:206-12.
6. Korver JE, Langewouters AM, Van De Kerkhof PC, Pasch MC. Therapeutic effects of a 12-week course of alefacept on nail psoriasis. J Eur Acad Dermatol Venereol. 2006;20:1252-5.
7. Reich K, Nestle FO, Papp K, Ortonne JP, Evans R, Guzzo C, et al. Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial. Lancet. 2005;366:1367-74.
8. Parrish CA, Sobera JO, Elewski BE. Modification of the nail psoriasis severity index. J Am Acad Dermatol. 2005;53:745-6.
9. Baran RL. A nail psoriasis severity index. Br J Dermatol. 2004;150:568-9.
10. Brazzelli V, Martinoli S, Prestinari F, Borroni G. An impressive therapeutic result of nail psoriasis to acitretin. J Eur Acad Dermatol Venereol. 2004;18:229-30.
11. Tosti A, Baran R, Dawber R, Haneke E. Treatment of common nail disorders. A text atlas of nail disorders: Techniques in investigation and diagnosis. 3rd ed. London: Taylor & Francis; 2003. p. 319-20.
12. Tosti A, Ricotti C, Romanelli P, Cameli N, Piraccini BM. Evaluation of the efficacy of acitretin therapy for nail psoriasis. Arch Dermatol. 2009;145:269-71.